Title: How Does Antiviral Technology Stack Up Against Enhanced Ventilation and Filtration Measures?

Abstract:

How does the Grignard Pure antiviral technology stack up against enhanced ventilation and filtration measures for airborne virus mitigation? Grignard Pure is not intended to replace the enhanced ventilation and filtration strategies recommended by the American Society of Heating, Refrigerating, and Air-Conditioning Engineers (ASHRAE) and the U.S. Centers for Disease Control and Prevention (CDC). Grignard Pure has been deployed as an additional layer of protection for public health in the fight against the COVID-19 pandemic. The product’s label directs users to follow public health officials’ advice, including enhanced ventilation and filtration guidance.
Grignard Pure can be introduced into an indoor space either through application equipment installed in an HVAC system or by a free-standing dispersion unit. Engineering studies show that aerosol quickly and evenly disperses throughout an indoor space and does so in both small and large spaces. (New Amsterdam Theatre Grignard Pure Proof of Concept Part 1: Enhanced Ventilation Studies and JBB: Grignard Pure Deployment Case Study.) commercially available sensors can measure the level of aerosol in space. In order to ensure a consistent, safe, and efficacious concentration of Grignard Pure in the air, proprietary software can use commercially available sensor measurements to automatically direct the dispersion equipment to maintain Grignard Pure at the concentration level within the EPA-approved concentration range once the target level is reached.
Three criteria are critical to examine when comparing an antimicrobial air treatment with enhanced ventilation and filtration measures. First, the amount of reduction: What percentage of the circulating virus is eliminated? Second, the speed with which the measure works: How quickly does the measure remove virus particles? Third, the mechanism of action—removal versus inactivation of the virus particles: How does the measure achieve its effect? A case Study will be presented to demonstrate the engineering principles developed and executed in the delivery technology and effectiveness of the Grignard Pure deployment.

Biography:

Mitch Simpler joined JB&B, a global consulting engineering firm, in 1977 and currently serves as a partner after having served as Managing Partner from 2012- 2018. He has acted as project manager and partner-in-charge on life/health science institutions, health care facilities, high-rise office buildings, museums, residential and mixed-use buildings, as well as hotels. Simpler’s list of notable projects in the life science sector spans the past 45 years, including premier laboratory facilities and research centers in New York City, such as the Jerome L. Greene Science Center at the Columbia University Manhattanville campus, The East River Science Park in New York, the New York Genome Center, Mount Sinai’s Hess Center for Science and Medicine, Weill Cornell Medical College’s Belfer Research Building, MSK’s David H. Koch Center for Cancer Care and Rockefeller Research Laboratories, Cornell University’s Biotechnology Building, and NYU Langone Health’s Smilow Research Building and Skirball Institute of Biomolecular Medicine. His experience extends around the world to China, with the Innovation Center at Duke Kunshan University in Kunshan and the Rohm & Haas Research Center in Shanghai. Mr. Simpler is a fellow of the American Council of Engineering Companies (ACEC) and recently served as the National Chairman of ACEC. He is also a founding member and Co-Founder of NYC Builds Bio+.